Delivery Order SPE2DB22D2206-SPE2DB25FJX41
- Not listed
- The U.S. Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Abraxane 100 mg vials valued at $7,565.23. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for completion by July 31, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of $8,558.34 worth of ABRAXANE 100 mg vials. The contract has a period of performance through January 31, 2024 and does not utilize any set-aside designations. This delivery order is issued under an indefinite delivery contract (IDC) that Amerisourcebergen Drug Corp holds with DLA, with a...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $28,620.65 by the Defense Logistics Agency's Medical Supply Chain for the procurement of Abraxane 100 mg vials. The contract, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, is structured as a firm fixed-price delivery order without a set-aside designation. Performance will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, where the company maintains its corporate...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the prime contractor, for the provision of ABRAXANE 100 MG VIALS. The contract has a potential value of $8,837.51 and a completion date of February 28, 2024. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a for-profit organization that provides pharmaceutical products and medical supplies to U.S. government agencies, including the Department of...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $23,240.98 firm fixed price delivery order is for the supply of ABRAXANE 100 MG VIALS, a specialty pharmaceutical product. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $41,294.87, is a Firm Fixed Price Delivery Order for the supply of ABRAXANE 100 MG VIALS, a specialty oncology medication. The contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,292.38, is for the delivery of ABRAXANE 100 MG VIALS, a specialty medication. The contract has an ultimate completion date of December 19, 2023 and is a firm fixed price delivery order. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This delivery order, awarded September 11, 2025, to AmerisourceBergen Drug Corp provides 100 mg vials of Abraxane, a chemotherapy medication used primarily in cancer treatment, with a ceiling value of $27,920.38. The contract is a firm fixed price, non-competitive set-aside delivery order that will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 12, 2025. The funding federal agency is the Medical Supply Chain,...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $24,640.84 to Amerisourcebergen Drug Corporation for 4561772767 units of ABRAXANE 100 MG VIALS. As the prime contractor, Amerisourcebergen will deliver the chemotherapy drug to its place of performance in Conshohocken, Pennsylvania by August 11, 2023 to support the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified. The delivery order was issued against an...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $25,931.08 to Amerisourcebergen Drug Corporation for 4561919850 units of ABRAXANE 100 MG VIALS. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products to a location in Conshohocken, Pennsylvania by August 24, 2023 under the terms of the contract. The Defense Logistics Agency is the Department of Defense's combat logistics support agency, responsible for...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJX41Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,258.76 to AmerisourceBergen Drug Corp for 100 mg vials of Abraxane, a chemotherapy medication. This non-competitive, firm fixed-price delivery order was awarded on September 12, 2025, with an ultimate completion date of September 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a critical federal vendor for medical procurement serving military and veteran healthcare systems through the DLA Medical Supply Chain. As a competitively awarded prime contractor with extensive experience fulfilling federal pharmaceutical requirements, AmerisourceBergen leverages its established IDC to deliver specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. This delivery order for Abraxane reflects the company's ongoing role in supporting Defense Health Agency medical needs and broader government healthcare systems through flexible contract mechanisms designed to ensure reliable access to essential pharmaceutical products.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.3k | 9/12/25 |